Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Gastroenterology | Family Medicine
Disease Category: Colorectal Cancer
Location: United States, ND
Clinical Trial Details
Research Study Summary
Metastatic Colorectal Cancer with wild-type KRAS tumors.
Objective response rate, duration of reponse, time to response, time to progression, disease control, overall survival, to evaluate changes in patient-reported outcomes.
Patient Inclusion Criteria:
- 18 + years
- Diagnosis of metastatic adenocarcinoma of the colon or rectum that cannot, in the opinon of the investigator, be cured by surgical resection at the time of randomization, wild-type KRAS expressing mCRC tumor, at least one uni-dimensionally measurable lesion
Patient Exclusion Criteria:
- adiotherapy <14 days before randomization, evidence of central nervous system metastases, history of other invasive primary cancer
To Learn more
Both Male and Female
Date Last Changed:
July 24, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.